Real-time enrollment status for this irritable bowel syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT07519395 |
| Recruiting Status | Recruiting |
| Condition | Irritable Bowel Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 420 participants |
| Active Locations | 110 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | June 25, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07519395 is currently recruiting participants. This clinical trial study for irritable bowel syndrome is actively seeking new participants at 110 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07519395 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 110 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07519395 was last updated 2 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.